-
Volunteers hit the streets for Eau Claire city's annual Spring Cleanup.More >> The search continues for a girl who went missing seventeen years ago.More >>
WASHINGTON (AP) -- The Food and Drug Administration is approving a weight loss drug from Vivus Inc. that many doctors consider the most effective among a new generation of anti-obesity pills.
The agency cleared the pill Qsymia for adults who are obese or overweight and have at least one weight-related condition such as high blood pressure, diabetes or high cholesterol.
The FDA says patients taking Qsymia for one year lost and average of 6.7 percent and 8.9 percent of their body weight in two studies. That was more than two other weight loss pills recently reviewed by the agency.
Qsymia is the second weight loss drug approved by the FDA in less than a month. In late June the agency approved Arena Pharmaceutical's pill Belviq.